Innovasan completes Med-San® proof of principle

“We are shifting our focus to design configuration and integration of each Med-San® stage into a working prototype.”

For Immediate Release
Release Date:
Thursday, June 26, 2014
 
Knoxville, TN – Innovasan has announced the successful completion of its SBIR Phase I research effort. The six-month research effort focused on achieving proof of principle for Med-San’s® final primary process cycle, wet oxidation.
 
Med-San® is comprised of three primary treatment phases beginning with a proprietary pre-treatment followed by ion infusion and wet oxidation. With the conclusion of the Phase I SBIR Innovasan announced the successful completion of proof of principle experiments for the final treatment stage, wet oxidation, marking the completion of proof of principle for each stage of Med-San® technology.
 
The successful wet oxidation was demonstrated through denaturation of the organic compound phenolphthalein, which bears a molecular structure similar to various pharmaceuticals and other organic compounds Med-San® is designed to destroy in waste streams.
 
“Successfully completing this Phase I SBIR and proof of principle for wet oxidation marks a major turning point for Innovasan. Now that we’ve successfully demonstrated proof of principle for the entire process we are shifting our focus to design configuration and integration of each Med-San® stage into a working prototype. Product development is the focus now. In the process of building a working prototype we are building custom continuous flow laboratory test apparatuses to optimize specific design details for the final integration of each stage into our working prototype,” said Jeff Hubrig Jr., Manager of Business Development.